Archives of gerontology and geriatrics · 2026
Clinical impact of cardiac ejection fraction and atrial fibrillation on elderly hemodialysis patients.
СтатьяМногоцентровое исследованиеНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Kim Da Woon, Hong Yu Ah, Shin Sung Joon, Kwon Soon Hyo, Chung Sungjin, Hyun Young Youl, Yu Byung Chul, Yang Jae Won, Hwang Won Min, Cho Jang-Hee, Yoo Kyung Don, Sun In O, Ko Gang-Jee, Kim Hyunsuk, Park Woo Yeong, Bae Eunjin, Song Sang Heon
Аннотация
BACKGROUND: This study aimed to investigate all-cause mortality in elderly patients starting hemodialysis (HD) according to left ventricular ejection fraction [LVEF] and atrial fibrillation (AF).
METHODS: We analyzed 1,137 incident HD patients aged ≥70 years from a retrospective multicenter cohort of the Korean Society of Geriatric Nephrology. All-cause mortality was evaluated within the first 6 months and beyond 6 months using a landmark analysis (median follow-up, 3.7 years) according to LVEF and AF status. Sequential Cox proportional hazards models were applied, adjusted for demographic and clinical factors.
RESULTS: Patients were classified into four groups according to LVEF (≥50% vs. <50%) and AF status. After full adjustment, neither reduced LVEF nor AF was independently associated with 6-month mortality. Early mortality was mainly associated with older age, lower serum albumin, and impaired mobility. In the 6-month landmark analysis, compared with patients with preserved LVEF and no AF, those with reduced LVEF without AF (hazard ratio [HR] 1.29, 95% confidence interval [CI] 1.01-1.65), preserved LVEF with AF (HR 1.35, 95% CI 1.02-1.80), and reduced LVEF with AF (HR 1.69, 95% CI 1.03-2.79) had progressively higher long-term mortality risks.
CONCLUSIONS: In elderly patients initiating HD, reduced LVEF and AF were independently associated with higher long-term mortality, whereas short-term mortality was predominantly driven by frailty and nutritional status rather than cardiac factors. These findings highlight the importance of time-specific risk stratification and integrated cardiovascular and geriatric management in this population.
METHODS: We analyzed 1,137 incident HD patients aged ≥70 years from a retrospective multicenter cohort of the Korean Society of Geriatric Nephrology. All-cause mortality was evaluated within the first 6 months and beyond 6 months using a landmark analysis (median follow-up, 3.7 years) according to LVEF and AF status. Sequential Cox proportional hazards models were applied, adjusted for demographic and clinical factors.
RESULTS: Patients were classified into four groups according to LVEF (≥50% vs. <50%) and AF status. After full adjustment, neither reduced LVEF nor AF was independently associated with 6-month mortality. Early mortality was mainly associated with older age, lower serum albumin, and impaired mobility. In the 6-month landmark analysis, compared with patients with preserved LVEF and no AF, those with reduced LVEF without AF (hazard ratio [HR] 1.29, 95% confidence interval [CI] 1.01-1.65), preserved LVEF with AF (HR 1.35, 95% CI 1.02-1.80), and reduced LVEF with AF (HR 1.69, 95% CI 1.03-2.79) had progressively higher long-term mortality risks.
CONCLUSIONS: In elderly patients initiating HD, reduced LVEF and AF were independently associated with higher long-term mortality, whereas short-term mortality was predominantly driven by frailty and nutritional status rather than cardiac factors. These findings highlight the importance of time-specific risk stratification and integrated cardiovascular and geriatric management in this population.